30.1%

of U.S. adults experience an anxiety disorder at some point in their lives (Source: National Institute of Mental Health / NCS-R)

60-80%

of patients achieve meaningful symptom reduction through structured CBT and Exposure Therapy (Source: Pubmed)

40-60%

of individuals find initial relief with first-line SSRI or SNRI pharmacotherapy (Source: The Lancet Systematic Reviews)

Advanced Interventions

Offering Deep TMS, IV Ketamine, and Spravato® for treatment-resistant anxiety

Different Types of Anxiety Disorders & Clinical Presentations

While temporary anxiety is a normal human reaction to stress, an anxiety disorder occurs when fear, dread, and physical tension become excessive, difficult to control, and persistent for months. It alters neurochemical pathways, overactivating the brain’s fear circuits, such as the amygdala, while dampening the prefrontal cortex’s ability to regulate emotional stress.

Common clinical presentations include:

Generalized Anxiety Disorder (GAD):  Persistent, uncontrollable worry about multiple everyday areas, including health, work, finances, and family.

Panic Disorder: Recurrent, sudden panic attacks accompanied by overwhelming physical fear and the constant dread of future attacks.

Social Anxiety Disorder: Intense fear of judgment, embarrassment, or scrutiny in social or performance settings.

Specific Phobias & Agoraphobia: Extreme avoidance of specific objects, situations, or environments where escape feels difficult.

Co-Occurring Traumatic & Obsessive Conditions: Complex anxiety frequently overlaps with PTSD or OCD, requiring specialized interventional protocols rather than a single generic approach.

Common Symptoms of Anxiety & Daily Life Impact

Anxiety manifests across cognitive, physical, and behavioral domains, often producing severe daily impairment:

Symptom Domain

Persistent Worry & Rumination

Physical Hyperarousal

Panic Attacks

Avoidance Behaviors

Cognitive Impairment

Sleep Disturbances

Social & Functional Strain

Common Impact on Daily Life

Uncontrollable racing thoughts, mental review loops, and catastrophic “what-if” thinking.

Muscle tension, rapid heart rate, shortness of breath, dizziness, sweating, and chronic fatigue.

Sudden surges of intense terror, chest tightness, trembling, and fear of losing control or dying.

Sidestepping places, social events, driving, or tasks that might trigger anxious distress.

Brain fog, scattered attention, poor concentration, and difficulty making routine decisions.

Insomnia, night waking, jaw clenching, and waking up with immediate morning dread.

Withdrawal from loved ones, irritability, missed workdays, and difficulty maintaining tasks.

FDA Status & Regulatory Context

Evidence-based anxiety care incorporates a range of FDA-cleared and evidence-based off-label interventional options.

Treatment Option

SSRIs & SNRIs (e.g., Sertraline, Duloxetine, Venlafaxine)

Buspirone & Selective Anxiolytics

Deep TMS Therapy

IV Ketamine Infusion Therapy

Spravato® (Esketamine) Nasal Spray

FDA Status

FDA-cleared for Anxiety Disorders

FDA-cleared for GAD

FDA-cleared for Depression & Anxious Depression

Evidence-based off-label use

FDA-cleared for TRD & MDD with Acute Suicidal Ideation

Primary Clinical Role

First-line oral pharmacotherapy for baseline serotonin/norepinephrine regulation

Non-sedating oral medication for chronic generalized worry

Non-invasive magnetic neuromodulation targeting underactive cortical circuits

Rapid glutamate NMDA antagonist resetting hyperactive fear circuitry

Targeted NMDA receptor modulation (Ideal for treatment-resistant anxiety with depression)

Evidence-Based Anxiety Treatment Modalities & Interventions

Cognitive Behavioral Therapy (CBT) & Exposure Therapy

CBT is the foundational psychotherapy for anxiety disorders. Under guided clinical supervision, CBT helps reframe catastrophic automatic thoughts (“I cannot cope”) and reduces safety behaviors. When combined with Exposure Therapy, patients gradually confront feared triggers in a controlled environment, allowing the nervous system to habituate and realize that anticipated catastrophes do not occur.

Specialized Medication Management

 First-line pharmacotherapy utilizes SSRIs (Selective Serotonin Reuptake Inhibitors) or SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors) to balance neurochemistry. Because these oral medications can take 4 to 8 weeks to achieve full therapeutic effect, and may cause initial side effects, our psychiatric prescribers provide careful dose titration, side-effect monitoring, and strategic augmentation (such as Buspirone) to ensure optimal stability.

Transcranial Magnetic Stimulation (Deep TMS Therapy)

Deep TMS is an FDA-cleared, non-invasive treatment for Major Depressive Disorder and comorbid anxiety symptoms (anxious depression). By delivering targeted magnetic pulses to stimulate underactive brain regions in the prefrontal cortex, Deep TMS rebalances dysregulated neural networks to reduce anxiety symptoms and depressive distress without systemic side effects or downtime.

Cognitive Behavioral Therapy (CBT) & Exposure Therapy

CBT is the foundational psychotherapy for anxiety disorders. Under guided clinical supervision, CBT helps reframe catastrophic automatic thoughts (“I cannot cope”) and reduces safety behaviors. When combined with Exposure Therapy, patients gradually confront feared triggers in a controlled environment, allowing the nervous system to habituate and realize that anticipated catastrophes do not occur.

Specialized Medication Management

 First-line pharmacotherapy utilizes SSRIs (Selective Serotonin Reuptake Inhibitors) or SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors) to balance neurochemistry. Because these oral medications can take 4 to 8 weeks to achieve full therapeutic effect, and may cause initial side effects, our psychiatric prescribers provide careful dose titration, side-effect monitoring, and strategic augmentation (such as Buspirone) to ensure optimal stability.

What to Expect During Your Anxiety Treatment

01

Free Consultation & Diagnostic Evaluation

Reach us at (954) 320-4944 or online. Our psychiatric team conducts a comprehensive evaluation of your anxiety history, physical symptoms, prior medication trials, and personal recovery goals.

02

Integrated Multi-Modal Treatment Planning

We collaborate with you to build a personalized treatment plan, combining Medication Management, CBT/Exposure strategies, Deep TMS, IV Ketamine, or Spravato based on your unique clinical profile and diagnosis.

03

In-Clinic Treatment Administration

Receive structured, monitored care in a comfortable clinical environment, whether attending daily 20-minute Deep TMS sessions, relaxing in a private suite during a 45-minute IV ketamine infusion, or receiving supervised Spravato administration.

04

Symptom Mapping & Skill Integration

We track anxiety reduction using standardized clinical metrics (e.g., GAD-7, HAM-A), helping you integrate new cognitive flexibility and physiological calmness into daily life.

05

Long-Term Monitoring & Maintenance

Ongoing follow-ups, precise medication adjustments, or periodic booster sessions ensure sustained neurological balance and prevent anxiety relapse.

Comparing OCD Treatment Options

Feature

Primary Mechanism

Therapeutic Onset

Administration

Anesthesia / Sedation

Driving Afterward

Best Suited For

Insurance Coverage

Psychotherapy (CBT / Exposure)

Cognitive reframing & behavioral habituation

8 to 12 weeks

Outpatient therapy sessions

None

Yes

Mild-to-severe anxiety & panic avoidance

Usually covered

Oral Medication Management (SSRIs/SNRIs)

Serotonin / Norepinephrine reuptake inhibition

4 to 8 weeks

Daily oral pill at home

None

Yes

Baseline serotonin/neurochemical stabilization

Usually covered

Deep TMS Therapy

Cortical magnetic neuromodulation

2 to 4 weeks

20-min daily in-clinic sessions

None (Fully awake)

Yes (Drive immediately)

Anxious depression & drug-resistant worry

Covered for qualifying indications

IV Ketamine Therapy

NMDA glutamate receptor antagonist

Hours to days

Monitored IV infusion in private suite

Mild dissociation / relaxation

No (Driver required)

Severe, intractable anxiety & acute crisis

Osmind claims assistance

Spravato® (Esketamine)

NMDA glutamate receptor antagonist

Hours to 24 hours

Supervised in-clinic nasal spray

Mild dissociation / sedation

No (Driver required)

Treatment-resistant anxiety co-occurring with TRD

Covered by most major plans

Why Choose Advanced Anxiety Therapies Over Standard Medication Alone

Medication Alone: Standard oral antidepressants can take up to two months to show full benefit, and up to 40% of patients experience incomplete relief or intolerable side effects. Advanced modalities like Deep TMS, IV Ketamine, and Spravato directly target underlying neural circuit dysregulation for faster, more comprehensive relief.

When Exposure Therapy Stalls: Exposure work requires confronting severe fear. For patients trapped in overwhelming hyperarousal, interventional treatments like Ketamine or Deep TMS lower physiological fear reactivity, enabling patients to engage fully and comfortably in behavioral therapy.

Comprehensive Multi-Modal Approach: Rather than relying on a single pill or temporary coping hack, Ketamine Wellness Clinic integrates central nervous system resets (Ketamine/Spravato), targeted brain stimulation (TMS), expert psychopharmacology, and therapeutic support for durable recovery.

Clinical Research & Data

CBT & Pharmacotherapy: Systematic meta-analyses published in The Lancet and Cochrane Database demonstrate that combining structured CBT with optimized SSRI/SNRI regimens produces significant clinical response in 60–70% of individuals with generalized anxiety and panic disorders. Clinical practice guidelines recommend CBT, SSRIs/SNRIs, or their combination as initial treatment options for generalized anxiety, panic disorder, and social anxiety disorder (Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis – Lancet, 2019).

Deep TMS for Anxious Depression: Multicenter clinical trials published in psychiatric literature confirmed that magnetic stimulation of the prefrontal cortex significantly reduces comorbid anxiety in depressed patients, establishing its FDA clearance specifically for anxious depression. NeuroStar TMS therapy is FDA-cleared for the treatment of major depressive disorder and to decrease anxiety symptoms in adult patients with MDD that may exhibit comorbid anxiety symptoms (NeuroStar TMS FDA Clearance for Anxious Depression). The NeuroStar Advanced Therapy System delivers TMS treatment in clinical settings for patients with depression, backed by the world’s largest depression outcomes registry of more than 15,000 patients (NeuroStar Clinical Results – Outcomes Registry).

Ketamine & Glutamate Pathways: Peer-reviewed clinical studies published in JAMA Psychiatry and the American Journal of Psychiatry demonstrate that subanesthetic IV ketamine rapidly reduces severe anxiety and treatment-resistant distress by modulating NMDA receptors and driving synaptic neuroplasticity. Ketamine acts as an NMDA receptor antagonist, modulating glutamate levels in the brain and enhancing neuroplasticity to promote the formation of new neural connections. Studies published in JAMA Psychiatry have found that up to 70% of individuals with treatment-resistant depression experienced significant improvement after ketamine infusions. Ketamine’s effects on synaptic plasticity explain its rapid and sustained antidepressant effects (Pubmed).

Insurance Coverage for Anxiety Treatment

We participate with major insurance carriers, including Aetna and Blue Cross Blue Shield, and utilize the Osmind platform to streamline out-of-network claims to maximize your reimbursement. Deep TMS and Spravato are widely covered by insurance for qualifying diagnoses, and our administrative team manages all benefit verifications and prior authorizations on your behalf.

Frequently Asked Questions About Anxiety Treatment

How do I know whether CBT, Medication, TMS, or Ketamine is right for my anxiety?

During your initial comprehensive evaluation, our psychiatric team reviews your symptom history, GAD-7 severity score, medical background, prior treatment responses, and insurance benefits to recommend a customized, multi-modal care plan.

Deep TMS is FDA-cleared specifically for Major Depressive Disorder with comorbid anxiety symptoms (anxious depression), rather than as a standalone clearance for isolated GAD or panic disorder. It safely uses gentle magnetic pulses to stimulate underactive prefrontal networks, restoring emotional balance without systemic drug side effects.

While traditional drugs target serotonin or GABA pathways slowly, Ketamine and Spravato modulate glutamate pathways to rapidly stimulate synaptic neuroplasticity. This interrupts rigid worry loops, calms hyperactive fear centers in the brain, and delivers rapid relief within hours to days.

You can drive home immediately following CBT, Medication Management, or Deep TMS sessions. For IV Ketamine and Spravato protocols, safety guidelines require an adult driver or ride service to transport you home due to transient dissociative or relaxing effects.

No. In most clinical cases, patients continue their prescribed oral medications. Advanced interventional treatments work synergistically alongside ongoing pharmacotherapy under direct medical supervision.

A standard Deep TMS protocol involves daily 20-minute sessions over 6 weeks. IV Ketamine typically involves an initial series of 6 infusions over 2 to 3 weeks, while Spravato follows a structured 8-week induction protocol before moving to maintenance.

If conventional oral medications have proven ineffective or caused unbearable side effects, our clinic specializes in advanced options, including medication dose tuning, Deep TMS Therapy, IV Ketamine Infusions, and Spravato® protocols tailored to your specific needs.

Find Out More

Contact us today and learn how Ketamine Clinic can guide your personal wellness journey.

By Appointment Only

Pompano Beach

41 N Federal Hwy, Suite A, 2nd Floor Pompano Beach, FL 33062

(954) 320-4944

(954) 400-5805

contact@ketamineclinicsouthflorida.com